Viral hepatitides in voluntary blood donors in Yola, Nigeria

European Journal of Scientific Research

Volumn 31, Issue 3, 2009, Pages 329-334

  Olokoba, A B ^a   Salawu, F K ^b   Danburam, A ^b   Desalu, O O ^c   Olokoba, L B ^c   Wahab, K W ^c   Badung, L H ^b   Tidi, S K ^b   Midala, J ^b   Aderibigbe, S ^c   Abdulrahman, M B ^c   Babalola, O M ^c   Abdukkarim, A ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b FEDERAL MEDICAL CENTER   (Nigeria)

^c Department of Medicine ^*

Author keywords

Blood donors; Nigeria; Viral hepatitides

Indexed keywords

EID: 67549140586     PISSN: 1450216X     EISSN: 1450202X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Abdalla F., O.W. Mwanda, F. Rana, 2005. Comparing walk-in and call-responsive donors in a national and a private hospital in Nairobi. East African Medical Journal.,82(10):532-536.
2. Behzad-Behbahani A., A. Mafi-Nejad, S.Z. Tabei, K.B. Lankarani, A. Torab, A. Moaddeb, 2006. Anti-HBc and HBV DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res.,123(1):3742.
3. Bhattacharya P., P.K. Chandra, S. Datta, A. Banerjee, S. Chakraborty, K. Rajendran K et al.,2007. Significant increase in HBV, HCV, HIV and Syphilis among blood donors in West Bengal, Eastern India. World J Gastroenterol.,13(27):3730-3733.
4. Bhatti F.A., Z. Ullah, N. Salamat, M. Ayub, E. Ghani, 2007. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice. Transfusion., 47(1):74-79.
5. Cheng D.S.,1995. Hepatitis C virus in chronic liver disease and Hepatocellular carcinoma in Taiwan. Princess Takamatsu symp., 25:27-32.
6. Colquhon S.D.,1996. Hepatitis C: A clinical update. Arch Surg.,131:18-23.
7. Egah D.Z., B.M. Mandong, D. Iya, N.E. Gomwalk, E.S. Audu, E.B. Banwat et al., 2004. Hepatitis C virus antibodies among blood donors in Jos, Nigeria. Annals of African Medicine., 3(1):35-37.
8. Ejele O.A., O. Erhabor, C.A. Nwauche, 2005. The risk of transfusion-transmissible viral infections in the Niger-Delta area of Nigeria. Sahel Medical Journal.,8(1):16-19.
9. Elfaki A.M., A.A. Eldour, N.M. Elsheikh, 2008. Sero-prevalence of immunodeficiency virus, hepatitis B and C and syphilis among blood donors at ElObeid Teaching Hospital, West Sudan. Sudan Journal of Medical Sciences.,3(4):333-338.
10. Esumeh F.I., D. Ugbomoiko, J.O. Isibor, 2003. Seroprevalence of HIV and Hepatitis B surface antigen (HBsAg) among blood donors in central hospital, Benin city, Nigeria. Journal of Medical Laboratory Science.,12(2):52-55.
11. Ezeani M.C., O. Oluchi, C.C. Onyenekwe, S.C. Meludu, J.E. Okonkwo, 2006. Prevalence of Hepatitis B and C virus infection among blood donors and abnormal ALT activities in blood donors in Nigeria. Journal of Biomedical Investigation.,4(2):32-36.
12. Fasola F.A., T.R. Kotila, J.O. Akinyemi, 2009. Trends in transfusion-transmissible viral infections from 2001 to 2006 in Ibadan, Nigeria. Intervirology.,51(6):427-431.
13. Gashau W., I. Mohammed, 1991. Hepatitis B virus markers in Nigerian patients with Primary Liver Cell Carcinoma. Trop Geog Med., 43:64-67.
14. th Ed. New York. Wilson JD, Braunwald E, Isselbacher K et al (eds). Mc Graw Hill.,1350-1352.
15. Kagu M.B., M.B. Kawuwa, A.O. Ayilara, B.Z. Ali, 2005. Seroprevalence of HIV and hepatitis viruses in directed blood donors: a preliminary report. Highland Medical Research Journal.,3(2):76-80.
16. Khan Z., F. Raziq, N. Aslam, 2002. Prevalence of HIV in N.W.F.P. Journal of Postgraduate Medical Institute.,16(2):187-189.
17. Lesi O.A., M.O. Kehinde, E.E. Anomneze, S.S. Wali, 2002. Hepatitis C infection and the risk of chronic liver disease in Lagos. Nig Q J Hosp Med.,12:1-4.
18. Maddava V., C. Burgess, E. Drucker, 2002. Epidemiology of chronic hepatitis co-infection in sub-Saharan Africa. Lancet, Infectious disease., 2:293-302.
19. Matee M.I., E.F. Lyamuya, E.C. Mbena, P.M. Magessa, J. Sufi, G.J. Marwa et al., 1999. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. East Afr Med J.,76(3):167-171.
20. Muktar H.M., A.M. Suleiman, M. Jones, 2005. Safety of blood transfusion: prevalence of hepatitis B surface antigen in blood donors in Zaria, Northern Nigeria. Nigerian journal of Surgical Research.,7(3&4): 290-292.
21. Nwokediuko S.C., O.G. Ibegbulam, T. Ugwu, 2007. Hepatitis C virus seroprevalence in blood donors at the University of Nigeria Teaching Hospital, Enugu. Journal of College of Medicine.,12(2):85-88.
22. Olokoba A.B., L.B. Olokoba, F.K. Salawu, A. Danburam, O.O. Desalu, J. Midala et al., 2008. Res. J. Med. Sci.,2(5):217-219.
23. Schreiber G.B., M.P. Busch, S.H. Kleinman, J.J. Korelitz, 1996. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med., 334:1685-1690.